VERNIA, FILIPPO
 Distribuzione geografica
Continente #
NA - Nord America 554
EU - Europa 323
AS - Asia 181
SA - Sud America 1
Totale 1.059
Nazione #
US - Stati Uniti d'America 548
IE - Irlanda 140
SG - Singapore 131
DE - Germania 54
CN - Cina 36
SE - Svezia 30
IT - Italia 21
CZ - Repubblica Ceca 19
FI - Finlandia 17
GB - Regno Unito 11
UA - Ucraina 8
TR - Turchia 7
AT - Austria 6
CA - Canada 6
FR - Francia 5
BE - Belgio 3
IN - India 2
RO - Romania 2
VN - Vietnam 2
AR - Argentina 1
IL - Israele 1
IS - Islanda 1
JP - Giappone 1
LT - Lituania 1
NL - Olanda 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.059
Città #
Chandler 155
Dublin 138
Singapore 107
Santa Clara 62
Jacksonville 43
Ashburn 32
Boardman 26
New York 22
Brno 19
Helsinki 16
Lawrence 16
Princeton 16
Bremen 15
Ann Arbor 13
Munich 11
Berlin 9
Wilmington 9
Shanghai 8
Frankfurt am Main 7
Des Moines 6
Izmir 6
L'aquila 6
Dallas 5
Los Angeles 5
San Mateo 5
Toronto 5
Fairfield 4
Nanjing 4
Beijing 3
Brussels 3
Cedar Knolls 3
Garner 3
Guangzhou 3
London 3
Nanchang 3
Nuremberg 3
Stockholm 3
Dearborn 2
Dong Ket 2
Jinan 2
L’Aquila 2
Morrisville 2
Mumbai 2
Norwalk 2
Phoenix 2
Redmond 2
Seattle 2
Vienna 2
Woodbridge 2
Amsterdam 1
Bologna 1
Bratislava 1
Buffalo 1
Chicago 1
Edinburgh 1
Fremont 1
Hamburg 1
Hangzhou 1
Huskvarna 1
Istanbul 1
Lappeenranta 1
Lincoln 1
Lisbon 1
Newark 1
Perugia 1
Pescara 1
Reykjavik 1
San Jose 1
Shenyang 1
Shijiazhuang 1
Southwark 1
Tel Aviv 1
Tianjin 1
Tokyo 1
Verona 1
Warsaw 1
Totale 848
Nome #
IgG4-Related Disease Mimicking Crohn's Disease: A Case Report and Review of Literature 89
Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin? 87
Metabolic Alterations in Celiac Disease Occurring after Following a Gluten-Free Diet 66
Is fecal calprotectin an accurate marker in the management of Crohn's disease? 58
Are volatile organic compounds accurate markers in the assessment of colorectal cancer and inflammatory bowel diseases? A review 56
Is mesalazine treatment effective in the prevention of diverticulitis? A review 53
Sleep disorders related to nutrition and digestive diseases: A neglected clinical condition 53
Fecal Lactoferrin and Other Putative Fecal Biomarkers in Crohn's Disease: Do They Still Have a Potential Clinical Role? 53
The usefulness of serum vitamin D levels in the assessment of IBD activity and response to biologics 51
Association of colonic diverticula with colorectal adenomas and cancer 51
Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis 48
Non-steroidal anti-inflammatory drugs and acetylsalicylic acid increase the risk of complications of diverticular disease: a meta-analysis of case–control and cohort studies 47
Risk of colonoscopic post-polypectomy bleeding in patients on single antiplatelet therapy: systematic review with meta-analysis 47
Serum transglutaminase antibodies do not always detect the persistent villous atrophy in patients with celiac disease on a gluten-free diet 45
Dietary factors modulating colorectal carcinogenesis 44
Vitamin D in Inflammatory Bowel Diseases. Mechanisms of Action and Therapeutic Implications 43
Is mastocytic colitis a specific clinical-pathological entity? 37
Immunoglobulin G4-Related Disease of the Intestine: A Clinicopathological Entity to Be Considered 33
Vaccine Acceptance in Patients with Inflammatory Bowel Disease: Lessons Learned from the COVID-19 Pandemic 20
The role of new inflammatory indices in the prediction of endoscopic and histological activity in inflammatory bowel disease patients 17
Effectiveness of Vitamin D Supplementation on Disease Course in Inflammatory Bowel Disease Patients: Systematic Review With Meta-Analysis 16
Deficit di micronutrienti e metabolismo osseo nella celiachia e nelle malattie infiammatorie croniche intestinali. 15
Low Vitamin K and Vitamin D Dietary Intake in Patients with Inflammatory Bowel Diseases 13
COVID-19 and Gastrointestinal Tract: From Pathophysiology to Clinical Manifestations 11
Adsorptive cytapheresis in ulcerative colitis: A non-pharmacological therapeutic approach revisited 10
IBD Patients with Primary or Secondary Nonresponse to Ustekinumab Benefit from Dose Escalation or Reinduction 9
Role of Ulcerative Colitis Endoscopic Index of Severity (UCEIS) versus Mayo Endoscopic Subscore (MES) in Predicting Patients' Response to Biological Therapy and the Need for Colectomy 9
A Practical Approach to Identify Non-Adherence to Mesalamine Therapy in Inflammatory Bowel Disease 8
Early hydrogen excretion peaks during breath tests. Small intestinal bacterial overgrowth or accelerated transit? 6
Posterior Reversible Encephalopathy Syndrome After Azathioprine Administration in Severe Ulcerative Colitis 6
Totale 1.101
Categoria #
all - tutte 6.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.136


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202031 0 0 0 0 0 6 10 2 7 1 0 5
2020/202175 2 8 1 7 5 2 7 12 10 3 14 4
2021/202289 4 0 14 2 2 4 1 8 4 0 5 45
2022/2023416 26 32 9 59 25 37 0 36 170 2 16 4
2023/2024153 12 2 5 2 8 34 12 6 0 5 24 43
2024/2025293 17 15 62 53 105 41 0 0 0 0 0 0
Totale 1.101